Geneva [Switzerland]: People with weaker immune systems should receive an additional shot of approved COVID-19 vaccines, an advisory group to the World Health Organisation (WHO) said on Monday.<\/p>\n
The recommendation follows a four-day meeting of the Strategic Advisory Group of Experts (SAGE) on Immunization. A final report will be issued in December, the WHO said in a statement.<\/p>\n
SAGE said moderately and severely immunocompromised persons should be offered an additional dose of all WHO-approved vaccines \u201csince these individuals are less likely to respond adequately to vaccination following a standard primary vaccine series and are at high risk of severe COVID-19 disease.\u201d<\/p>\n
People aged 60 and older who received the Sinovac and Sinopharm vaccines should get a third dose too, the experts added, though the use of other vaccines may also be considered depending on supply and access, the WHO informed.<\/p>\n
\u201cWhen implementing this recommendation, countries should initially aim at maximising 2-dose coverage in that population, and thereafter administer the third dose, starting in the oldest age groups\u201d, they said.<\/p>\n
SAGE has also reviewed a vaccine developed by Indian company Bharat Biotech and will issue a policy recommendation after WHO greenlights it for emergency use.<\/p>\n
Last week, the WHO has also announced a plan to end the COVID-19 pandemic by ensuring all people, everywhere, have access to vaccines.<\/p>\n
The plan calls for inoculating 40 per cent of people in all countries by the end of the year, and 70 per cent by the middle of 2022.<\/p>\n
The strategy takes a three-step approach to vaccination. Priority is given to older people, health workers, and high-risk groups of all ages, followed by adults and then adolescents.<\/p>\n","protected":false},"excerpt":{"rendered":"
Geneva [Switzerland]: People with weaker immune systems should receive an additional shot of approved COVID-19 vaccines, an advisory group to the World Health Organisation (WHO) said on Monday. The recommendation follows a four-day meeting of the Strategic Advisory Group of Experts (SAGE) on Immunization. A final report will be issued in December, the WHO said […]<\/p>\n","protected":false},"author":1,"featured_media":7965,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[],"class_list":{"0":"post-7964","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-international"},"_links":{"self":[{"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=\/wp\/v2\/posts\/7964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7964"}],"version-history":[{"count":1,"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=\/wp\/v2\/posts\/7964\/revisions"}],"predecessor-version":[{"id":7966,"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=\/wp\/v2\/posts\/7964\/revisions\/7966"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=\/wp\/v2\/media\/7965"}],"wp:attachment":[{"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ncrfrontlinenews.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}